Multicentric Phase II Study of Concomitant Chemo-Radiotherapy in Locally Advanced Non Small Cell Lung Cancer, With :- Induction Chemotherapy by Cisplatin - Docetaxel- Concomitant Chemo-Radiotherapy by Weekly Cisplatin – Docetaxel- Consolidation Chemotherapy by Docetaxel.
Latest Information Update: 07 Oct 2025
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 10 Sep 2025 Actual primary completion date changed to 1 May 2004.
- 10 Sep 2025 Status changed from discontinued to withdrawn prior to enrolment.
- 23 Jan 2008 The expected completion date for this trial is now 1 Mar 2007.